References
1.
Wang, J., & Christo, P. J. (2009). The Influence of Prescription Monitoring Programs on Chronic Pain Management. Pain Physician May 2009, 3;12(3;5), 507-515. doi:10.36076/ppj.2009/12/507
2.
Rutkow L., Turner L., Lucas E., Hwang C., & Alexander G. C. (2015). Most Primary Care Physicians Are Aware Of Prescription Drug Monitoring Programs, But Many Find The Data Difficult To Access. Health Affairs, 34(3), 484-492. doi:10.1377/hlthaff.2014.1085
3.
Patrick, S. W., & Schiff, D. M. (2017). A Public Health Response to Opioid Use in Pregnancy. Pediatrics, 139(3). doi:10.1542/peds.2016-4070
4.
Committee Opinion No. 711 Summary: Opioid Use and Opioid Use Disorder in Pregnancy. (2017). Obstetrics & Gynecology, 130(2), 488-489. doi:10.1097/aog.0000000000002229
5.
National Institute on Drug Abuse. (2021, April 13). Part 1: The Connection Between Substance Use Disorders and Mental Illness. Retrieved from https://www.drugabuse.gov/publications/research-reports/common-comorbidities-substance-use-disorders/part-1-connection-between-substance-use-disorders-mental-illness
6.
Katz C, El-Gabalawy R, Keyes KM, Martins SS, Sareen J. Risk factors for incident nonmedical prescription opioid use and abuse and dependence: results from a longitudinal nationally representative sample. Drug Alcohol Depend. 2013;132(1-2):107-113. doi:10.1016/j.drugalcdep.2013.01.010.